PDF(Pubmed)
Abstract：
BACKGROUND: Trichilemmal carcinoma (TLC) is a rare malignant cutaneous adnexal tumor usually accept surgery. This report describes an elderly patient with recurrence TLC of the periorbital region after surgery who was subsequently treated with IMRT radiotherapy. After 2-years follow-up visit, there was no progress or metastasis.
BACKGROUND: TLC is a rare malignant cutaneous adnexal tumor. It usually occurs on sun-exposed areas in elderly people but rarely occurs in the periorbital region. Most cases accept surgery or micrographic Mohs surgery. Recurrence or metastasis of this neoplasm was seldom reported in the medical literature after enough tumor-free margin surgery. And radiotherapy was seldom reported in the treatment for patients of TLC.
METHODS: Here we report an elderly patient with recurrence TLC of the periorbital region after surgery who was subsequently treated with radiotherapy with a total dose of 66 Gy. Two years later, the patient was admitted head, neck, chest, abdomen CT scan, and no progress or metastasis was detected after 2-years follow-up.
METHODS: Trichilemmal carcinoma of the periorbital region.
METHODS: We describe the clinical characteristics, pathological features, and choice of examination methods of a patient with TLC in the periorbital region. And we use the radical radiotherapy to treat this case.
RESULTS: There are no progress or metastasis after 2-years follow-up.
CONCLUSIONS: Radiotherapy is a good option for patients with TLC if the patient refuses surgery or fails to achieve a satisfactory tumor-free margin or relapses after surgery.
BACKGROUND: TLC is a rare malignant cutaneous adnexal tumor. It usually occurs on sun-exposed areas in elderly people but rarely occurs in the periorbital region. Most cases accept surgery or micrographic Mohs surgery. Recurrence or metastasis of this neoplasm was seldom reported in the medical literature after enough tumor-free margin surgery. And radiotherapy was seldom reported in the treatment for patients of TLC.
METHODS: Here we report an elderly patient with recurrence TLC of the periorbital region after surgery who was subsequently treated with radiotherapy with a total dose of 66 Gy. Two years later, the patient was admitted head, neck, chest, abdomen CT scan, and no progress or metastasis was detected after 2-years follow-up.
METHODS: Trichilemmal carcinoma of the periorbital region.
METHODS: We describe the clinical characteristics, pathological features, and choice of examination methods of a patient with TLC in the periorbital region. And we use the radical radiotherapy to treat this case.
RESULTS: There are no progress or metastasis after 2-years follow-up.
CONCLUSIONS: Radiotherapy is a good option for patients with TLC if the patient refuses surgery or fails to achieve a satisfactory tumor-free margin or relapses after surgery.
摘要：
背景：毛膜癌（TLC）是一种罕见的恶性皮肤附件肿瘤，通常需要手术治疗。该报告描述了一名老年患者，该患者在手术后眶周区域复发TLC，随后接受了IMRT放疗。经过两年的随访，没有进展或转移。
背景：TLC是一种罕见的恶性皮肤附件肿瘤。它通常发生在老年人的阳光照射区域，但很少发生在眶周区域。大多数病例接受手术或显微照片Mohs手术。在足够的无瘤切缘手术后，医学文献中很少报道这种肿瘤的复发或转移。在TLC患者的治疗中很少报道放射治疗。
方法：在这里，我们报告了一名老年患者，术后眶周区TLC复发，随后接受了总剂量为66Gy的放射治疗。两年后,病人头部入院，脖子,胸部，腹部CT扫描,随访2年未发现进展或转移。
方法：眶周区三膜癌。
方法：我们描述了临床特征，病理特征,以及选择在眶周区域进行TLC的患者的检查方法。我们使用根治性放疗来治疗这种情况。
结果：随访2年无进展或转移。
结论：如果患者拒绝手术或未能达到满意的无瘤切缘或术后复发，放疗是TLC患者的良好选择。
背景：TLC是一种罕见的恶性皮肤附件肿瘤。它通常发生在老年人的阳光照射区域，但很少发生在眶周区域。大多数病例接受手术或显微照片Mohs手术。在足够的无瘤切缘手术后，医学文献中很少报道这种肿瘤的复发或转移。在TLC患者的治疗中很少报道放射治疗。
方法：在这里，我们报告了一名老年患者，术后眶周区TLC复发，随后接受了总剂量为66Gy的放射治疗。两年后,病人头部入院，脖子,胸部，腹部CT扫描,随访2年未发现进展或转移。
方法：眶周区三膜癌。
方法：我们描述了临床特征，病理特征,以及选择在眶周区域进行TLC的患者的检查方法。我们使用根治性放疗来治疗这种情况。
结果：随访2年无进展或转移。
结论：如果患者拒绝手术或未能达到满意的无瘤切缘或术后复发，放疗是TLC患者的良好选择。
